SCHEMBL352177

SCHEMBL352177

ON=Cc1ccncc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL591208 1.00
SCHEMBL982231 1.00
Hydrochloric Acid SCHEMBL6901823 0.97 ACHE (0.45)
Bromide SCHEMBL28108732 0.97 ACHE (0.45)
Bromide SCHEMBL7180391 0.97 ACHE (0.45)
Iodomethane SCHEMBL8058645 0.93 ACHE (0.47)
SCHEMBL29720380 0.85 KMT2A (0.44)
SCHEMBL9712709 0.85 KMT2A (0.44)
Isonicotinonitrile SCHEMBL27701693 0.84 GRK2 (0.48)
SCHEMBL4275683 0.80 KMT2A (0.64)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 252 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118858251-A Method for detecting iron oxide content in dolomite based on Raman spectrum principle 武宣宝丰矿业有限公司 2024-10-29 CN claimed
US-12071653-B2 Methods and systems for nucleic acid sequencing ULTIMA GENOMICS, INC. (US) 2024-08-27 US claimed
CN-118206565-A Catalytic marking reagent with phosphatidylserine targeting function and micro-region proteome marking and identifying method 中国科学院大连化学物理研究所 2024-06-18 CN claimed
US-20220348994-A1 METHODS AND SYSTEMS FOR NUCLEIC ACID SEQUENCING ULTIMA GENOMICS, INC. 2022-11-03 US claimed
US-11326203-B2 Methods and systems for nucleic acid sequencing ULTIMA GENOMICS, INC. (US) 2022-05-10 US claimed
CN-112830913-A Method for preparing 2, 5-furan diformylaldoxime 中国科学院宁波材料技术与工程研究所 2021-05-25 CN claimed
US-20200318170-A1 METHODS AND SYSTEMS FOR NUCLEIC ACID SEQUENCING ULTIMA GENOMICS, INC. 2020-10-08 US claimed
WO-2019067635-A1 METHODS AND SYSTEMS FOR NUCLEIC ACID SEQUENCING ULTIMA GENOMICS, INC. (US) 2019-04-04 WO claimed
US-10202513-B2 Coating composition comprising anti-skinning agent PPG COATINGS EUROPE B.V. (NL) 2019-02-12 US claimed
US-20170253752-A1 Coating Composition Comprising Anti-Skinning Agent PPG COATINGS EUROPE B.V. (NL) 2017-09-07 US claimed
EP-3204459-A1 COATING COMPOSITION COMPRISING ANTI-SKINNING AGENT PPG Europe B.V. (NL) 2017-08-16 EP claimed
WO-2016055114-A9 COATING COMPOSITION COMPRISING ANTI-SKINNING AGENT PPG EUROPE B.V. (NL) 2016-06-02 WO claimed
WO-2016055114-A1 COATING COMPOSITION COMPRISING ANTI-SKINNING AGENT PPG EUROPE B.V. (NL) 2016-04-14 WO claimed
US-8404850-B2 Bis-quaternary pyridinium-aldoxime salts and treatment of exposure to cholinesterase inhibitors SOUTHWEST RESEARCH INSTITUTE (US) 2013-03-26 US claimed
US-20120205591-A1 SELF INDICATING RADIATION ALERT DOSIMETER PATEL GORDHABHAI N (US) 2012-08-16 US claimed
EP-1490044-A4 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORP (US) 2008-04-16 EP claimed
EP-1490044-A1 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORPORATION (US) 2004-12-29 EP claimed
WO-2003084524-A1 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORPORATION (US) 2003-10-16 WO claimed
EP-0906773-A1 Decontaminating composition Etat-Francais représenté par le Délégué Général pour L'Armement (FR) 1999-04-07 EP claimed
US-12637426-B2 1-cyano-pyrrolidine compounds as USP30 inhibitors MISSION THERAPEUTICS LIMITED (GB) 2026-05-26 US disclosed
EP-4688161-A1 IL4I1 INHIBITORS AND METHODS OF USE Merck Sharp & Dohme LLC (US) 2026-02-11 EP disclosed
EP-4678648-A1 SYNTHESIS METHOD OF ANTIBODY-DRUG CONJUGATES USING PROXIMITY EFFECT-BASED SITE-SELECTIVE ANTIBODY LABELING Sogang University Research Business Development Foundation (KR) 2026-01-14 EP disclosed
US-20250186608-A1 NANODIAMONDS AS DELIVERY PLATFORM FOR OXIME ANTIDOTES TO CENTRAL NERVOUS SYSTEM IN ORGANOPHOSPHATE POISONING TALLINN UNIVERSITY OF TECHNOLOGY (EE) 2025-06-12 US disclosed
WO-2025085347-A1 IL4I1 INHIBITORS AND USES THEREOF MERCK SHARP & DOHME LLC (US) 2025-04-24 WO disclosed
US-20250059593-A1 METHODS AND SYSTEMS FOR NUCLEIC ACID SEQUENCING ULTIMA GENOMICS, INC. (US) 2025-02-20 US disclosed
US-12215082-B1 (e)-1-(2-(4-substitutedphenyl)-2-oxoethyl)-4-((hydroxyimino)methyl)pyridinium bromides as antitubercular agents King Faisal University (SA) 2025-02-04 US disclosed
CN-118858251-A Method for detecting iron oxide content in dolomite based on Raman spectrum principle 武宣宝丰矿业有限公司 2024-10-29 CN disclosed
CN-118858251-A Method for detecting iron oxide content in dolomite based on Raman spectrum principle 武宣宝丰矿业有限公司 2024-10-29 CN disclosed
US-20240336608-A1 IL4I1 INHIBITORS AND METHODS OF USE MERCK SHARP & DOHME LLC (US) 2024-10-10 US disclosed
WO-2024206357-A1 IL4I1 INHIBITORS AND METHODS OF USE MERCK SHARP & DOHME LLC (US) 2024-10-03 WO disclosed
WO-2024186075-A1 SYNTHESIS METHOD OF ANTIBODY-DRUG CONJUGATES USING PROXIMITY EFFECT-BASED SITE-SELECTIVE ANTIBODY LABELING 서강대학교산학협력단 2024-09-12 WO disclosed
US-12071653-B2 Methods and systems for nucleic acid sequencing ULTIMA GENOMICS, INC. (US) 2024-08-27 US disclosed
CN-118206565-A Catalytic marking reagent with phosphatidylserine targeting function and micro-region proteome marking and identifying method 中国科学院大连化学物理研究所 2024-06-18 CN disclosed
EP-3810723-B1 COATING COMPOSITION PPG EUROPE B V (NL) 2024-02-21 EP disclosed
CN-113087722-B Tricyclic isoxazole compound and preparation method and application thereof 中国人民解放军海军军医大学 2023-04-28 CN disclosed
CN-110606827-B One-step method for synthesizing methylaminopyridine compounds 西安凯立新材料股份有限公司 2023-03-14 CN disclosed
WO-2022240241-A1 POLYIMIDE PRECURSOR COMPOSITION AND POLYIMIDE USING SAME 피아이첨단소재 주식회사 2022-11-17 WO disclosed
US-20220348994-A1 METHODS AND SYSTEMS FOR NUCLEIC ACID SEQUENCING ULTIMA GENOMICS, INC. 2022-11-03 US disclosed
EP-3077467-B1 DRIER COMPOSITION AND USE THEREOF PPG EUROPE B V (NL) 2022-11-02 EP disclosed
US-20220251041-A1 1-CYANO-PYRROLIDINE COMPOUNDS AS USP30 INHIBITORS MISSION THERAPEUTICS LTD (GB) 2022-08-11 US disclosed
US-11390584-B2 1-cyano-pyrrolidine compounds as USP30 inhibitors MISSION THERAPEUTICS LIMITED (GB) 2022-07-19 US disclosed
US-11326203-B2 Methods and systems for nucleic acid sequencing ULTIMA GENOMICS, INC. (US) 2022-05-10 US disclosed
CN-109438471-B Tricyclic isoxazole compound and preparation method and application thereof 中国人民解放军第二军医大学 2021-09-17 CN disclosed
CN-113087722-A Tricyclic isoxazole compound and preparation method and application thereof 中国人民解放军海军军医大学 2021-07-09 CN disclosed
CN-112830913-A Method for preparing 2, 5-furan diformylaldoxime 中国科学院宁波材料技术与工程研究所 2021-05-25 CN disclosed
EP-3810723-A1 COATING COMPOSITION PPG Europe B.V. (NL) 2021-04-28 EP disclosed
US-10954506-B2 Polymer engineered regenerating bioscavengers CARNEGIE MELLON UNIVERSITY (US) 2021-03-23 US disclosed
US-10947525-B2 Polymer engineered regenerating bioscavengers CARNEGIE MELLON UNIVERSITY (US) 2021-03-16 US disclosed
US-20200318170-A1 METHODS AND SYSTEMS FOR NUCLEIC ACID SEQUENCING ULTIMA GENOMICS, INC. 2020-10-08 US disclosed
CN-107652242-B Synthesis of pyrimidine salicylic acid oxime ester and application of pyrimidine salicylic acid oxime ester as herbicide 中国农业大学 2020-07-31 CN disclosed
CN-107056773-B Pyrazole dioxa (thia) diazole compound containing pyridinium salt and preparation method and application thereof 贵州大学 2020-07-14 CN disclosed
WO-2019243546-A1 COATING COMPOSITION PPG EUROPE B.V. (NL) 2019-12-26 WO disclosed
CN-110606827-A One-step method for synthesizing methylaminopyridine compounds 西安凯立新材料股份有限公司 2019-12-24 CN disclosed
US-10400232-B2 Polymer engineered regenerating bioscavengers CARNEGIE MELLON UNIVERSITY (US) 2019-09-03 US disclosed
WO-2019067635-A1 METHODS AND SYSTEMS FOR NUCLEIC ACID SEQUENCING ULTIMA GENOMICS, INC. (US) 2019-04-04 WO disclosed
US-10202513-B2 Coating composition comprising anti-skinning agent PPG COATINGS EUROPE B.V. (NL) 2019-02-12 US disclosed
EP-2231651-B1 ISOXAZOLO-PYRIDAZINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2018-11-21 EP disclosed
US-20180265470-A1 Drier Composition and Use Thereof PPG EUROPE B V (NL) 2018-09-20 US disclosed
CN-107652242-A A kind of synthesis of pyrimidine salicylic acid oxime ester and the application as herbicide 中国农业大学 2018-02-02 CN disclosed
EP-3228730-A1 ETCHING AGENT AND REPLENISHING SOLUTION THEREFOR, METHOD FOR ROUGHENING SURFACE OF MAGNESIUM COMPONENT, AND METHOD FOR MANUFACTURING MAGNESIUM-RESIN COMPOSITE MEC COMPANY LTD. (JP) 2017-10-11 EP disclosed
US-20170268112-A1 ETCHING AGENT AND REPLENISHING SOLUTION THEREFOR, METHOD FOR ROUGHENING SURFACE OF MAGNESIUM COMPONENT, AND METHOD FOR MANUFACTURING MAGNESIUM-RESIN COMPOSITE MEC COMPANY LTD. (JP) 2017-09-21 US disclosed
US-20170253752-A1 Coating Composition Comprising Anti-Skinning Agent PPG COATINGS EUROPE B.V. (NL) 2017-09-07 US disclosed
EP-3204459-A1 COATING COMPOSITION COMPRISING ANTI-SKINNING AGENT PPG Europe B.V. (NL) 2017-08-16 EP disclosed
CN-107018669-A The manufacture method of etchant and its bulking liquor, the method for coarsening surface of magnesium component and magnesium-resin composite body MEC股份有限公司 2017-08-04 CN disclosed
US-20170023681-A1 PERSONAL AND SELF INDICATING RADIATION ALERT DOSIMETER NEW YORK UNIVERSITY 2017-01-26 US disclosed
CN-103864754-B Five-membered azole heterocycle compound and preparation method thereof, pharmaceutical composition and purposes 中国科学院上海药物研究所 2016-12-21 CN disclosed
US-20160304747-A1 Drier Composition and Use Thereof PPG EUROPE B.V. (NL) 2016-10-20 US disclosed
EP-3077467-A1 DRIER COMPOSITION AND USE THEREOF PPG Europe B.V. (NL) 2016-10-12 EP disclosed
US-20160244741-A1 POLYMER ENGINEERED REGENERATING BIOSCAVENGERS CARNEGIE MELLON UNIVERSITY 2016-08-25 US disclosed
WO-2016055114-A9 COATING COMPOSITION COMPRISING ANTI-SKINNING AGENT PPG EUROPE B.V. (NL) 2016-06-02 WO disclosed
WO-2016055114-A1 COATING COMPOSITION COMPRISING ANTI-SKINNING AGENT PPG EUROPE B.V. (NL) 2016-04-14 WO disclosed
US-9295674-B2 Metalloporphyrin neurological treatments THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2016-03-29 US disclosed
US-9227937-B2 Phenoxyalkyl pyridinium oxime therapeutics for treatment of organophosphate poisoning MISSISSIPPI STATE UNIVERSITY (US) 2016-01-05 US disclosed
US-9227937-B2 Phenoxyalkyl pyridinium oxime therapeutics for treatment of organophosphate poisoning MISSISSIPPI STATE UNIVERSITY (US) 2016-01-05 US disclosed
US-20150246057-A1 Metalloporphyrin Neurological Treatments THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2015-09-03 US disclosed
EP-2767536-B1 Isoxazolo-pyridine derivatives HOFFMANN LA ROCHE (CH) 2015-09-02 EP disclosed
US-20150216993-A1 MULTIFUNCTIONAL SMALL MOLECULES THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2015-08-06 US disclosed
US-9086489-B2 Personal and area self-indicating instant radiation alert dosimeter JP LABORATORIES, INC (US) 2015-07-21 US disclosed
US-9073908-B2 Isoxazolo-pyridine derivatives ROCHE PALO ALTO LLC (US) 2015-07-07 US disclosed
WO-2015082553-A1 DRIER COMPOSITION AND USE THEREOF PPG EUROPE B.V. (NL) 2015-06-11 WO disclosed
US-9028873-B2 Nanoparticles for drug delivery to the central nervous system SOUTHWEST RESEARCH INSTITUTE (US) 2015-05-12 US disclosed
WO-2015051326-A1 POLYMER ENGUNEERED REGENERATING BIOSCAVENGERS CARNEGIE MELLON UNIVERSITY (US) 2015-04-09 WO disclosed
EP-2227467-B1 ISOXAZOLO-PYRIDINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2014-12-31 EP disclosed
US-8877782-B2 Isoxazolo-pyridine derivatives ROCHE PALO ALTO LLC (US) 2014-11-04 US disclosed
US-8877783-B2 Isoxazolo-pyridine derivatives ROCHE PALO ALTO LLC (US) 2014-11-04 US disclosed
US-8872134-B2 Self indicating radiation alert dosimeter JP LABORATORIES, INC (US) 2014-10-28 US disclosed
EP-2785339-A2 METALLOPORPHYRIN NEUROLOGICAL TREATMENTS The Regents of the University of Colorado, a body corporate (US) 2014-10-08 EP disclosed
US-8846719-B2 Isoxazolo-pyridine derivatives ROCHE PALO ALTO LLC (US) 2014-09-30 US disclosed
EP-2767536-A1 ISOXAZOLO-PYRIDINE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2014-08-20 EP disclosed
US-8759376-B2 Isoxazole and isothiazole compounds useful in the treatment of inflammation THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH (US) 2014-06-24 US disclosed
CN-103864754-A Five-membered azole heterocycle compound, preparation method, drug composition and use thereof SHANGHAI INST MATERIA MEDICA 2014-06-18 CN disclosed
US-8722706-B2 Two phase bioactive formulations of bis-quaternary pyridinium oxime sulfonate salts SOUTHWEST RESEARCH INSTITUTE (US) 2014-05-13 US disclosed
EP-2440542-B1 Substituted benzimidazoles, benzonthiazoles and benzoxazoles GRUENENTHAL GMBH (DE) 2013-12-18 EP disclosed
CN-103402996-A Indole compounds or analogues thereof useful for the treatment of age-related macular degeneration (AMD) NOVARTIS AG 2013-11-20 CN disclosed
US-20130281690-A1 ISOXAZOLO-PYRIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2013-10-24 US disclosed
EP-2366704-B1 Inhibitors of serine proteases VERTEX PHARMA (US) 2013-10-23 EP disclosed
US-20130274467-A1 ISOXAZOLO-PYRIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2013-10-17 US disclosed
US-20130274468-A1 ISOXAZOLO-PYRIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2013-10-17 US disclosed
US-20130274469-A1 ISOXAZOLO-PYRIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2013-10-17 US disclosed
WO-2013130150-A2 METALLOPORPHYRIN NEUROLOGICAL TREATMENTS THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2013-09-06 WO disclosed
EP-2631238-A1 Spirocyclic inhibitors of serine proteases for the treatment of hcv infections VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-08-28 EP disclosed
US-8518974-B2 Isoxazolo-pyridine derivatives Hoffmann-La Roche Inc (US) 2013-08-27 US disclosed
US-8492559-B2 Substituted indole compounds GRUENENTHAL GMBH (DE) 2013-07-23 US disclosed
US-20130172393-A1 PHENOXYALKYL PYRIDINIUM OXIME THERAPEUTICS FOR TREATMENT OF ORGANOPHOSPHATE POISONING MISSISSIPPI STATE UNIVERSITY 2013-07-04 US disclosed
US-20130172393-A1 PHENOXYALKYL PYRIDINIUM OXIME THERAPEUTICS FOR TREATMENT OF ORGANOPHOSPHATE POISONING MISSISSIPPI STATE UNIVERSITY 2013-07-04 US disclosed
EP-2393812-B1 SUBSTITUTED SPIROAMIDES AS B1R-MODULATORS GRUENENTHAL GMBH (DE) 2013-07-03 EP disclosed
US-8404850-B2 Bis-quaternary pyridinium-aldoxime salts and treatment of exposure to cholinesterase inhibitors SOUTHWEST RESEARCH INSTITUTE (US) 2013-03-26 US disclosed
US-20130058910-A1 DECONTAMINATION OF CHEMICAL AND BIOLOGICAL AGENTS PITTSBURGH, UNIVERSITY OF - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2013-03-07 US disclosed
US-8357717-B2 Spiro group-containing amide compounds having bradykinin 1 receptor (B1R) activity GRUENENTHAL GMBH (DE) 2013-01-22 US disclosed
US-8354219-B2 Photosensitive resin composition and dry film comprising the same LG CHEM, LTD. (KR) 2013-01-15 US disclosed
CN-101889010-B Isoxazolo-pyridine derivatives HOFFMANN LA ROCHE 2012-12-05 CN disclosed
CN-101868458-B Isoxazolo-pyridazine derivatives HOFFMANN LA ROCHE 2012-11-28 CN disclosed
US-8268814-B2 Substituted sulfonamide compounds GRUENENTHAL GMBH (DE) 2012-09-18 US disclosed
US-20120205591-A1 SELF INDICATING RADIATION ALERT DOSIMETER PATEL GORDHABHAI N (US) 2012-08-16 US disclosed
US-8232288-B2 Substituted benzimidazoles, benzothiazoles and benzoxazoles GRUENENTHAL GMBH (DE) 2012-07-31 US disclosed
US-8227617-B2 Process for preparing 2-hydroxy-4-substituted pyridines YUKI GOSEI KOGYO CO., LTD. (JP) 2012-07-24 US disclosed
US-8227234-B2 Process for preparing 2-hydroxy-4-substituted pyridines YUKI GOSEI KOGYO CO., LTD. (JP) 2012-07-24 US disclosed
US-20120181453-A1 PERSONAL AND AREA SELF-INDICATING INSTANT RADIATION ALERT DOSIMETER JP LABORATORIES INC. 2012-07-19 US disclosed
US-20120184538-A1 ISOXAZOLO-PYRIDINE DERIVATIVES HOFFMANN-LA ROCHE INC. 2012-07-19 US disclosed
CN-101048380-B Process for production of 2-hydroxy-4-substituted pyridines YUKI GOSEI YAKUHIN KOGYO KK 2012-06-20 CN disclosed
CN-1922486-B Detection of biomolecules using porous biosensors and Raman spectroscopy INTEL CORP 2012-06-20 CN disclosed
EP-2440542-A1 SUBSTITUTED BENZIMIDAZOLES, BENZOTHIAZOLES AND BENZOXAZOLES Grünenthal GmbH (DE) 2012-04-18 EP disclosed
US-8115182-B1 Personal and area self-indicating radiation alert dosimeter JP LABORATORIES INC. 2012-02-14 US disclosed
US-20120012366-A1 POLYAMIC ACID, POLYIMIDE, PHOTOSENSITIVE RESIN COMPOSITION COMPRISING THE SAME, AND DRY FILM MANUFACTURED FROM THE SAME LG CHEM, LTD. (KR) 2012-01-19 US disclosed
EP-2393803-A1 SUBSTITUTED INDOLE COMPOUNDS AS BRADYKININ RECEPTOR 1 MODULATORS Grünenthal GmbH (DE) 2011-12-14 EP disclosed
US-20110278049-A1 PHOTOSENSITIVE RESIN COMPOSITION AND DRY FILM COMPRISING THE SAME LG CHEM, LTD. (KR) 2011-11-17 US disclosed
WO-2011142826-A1 PHENOXYALKYL PYRIDINIUM OXIME THERAPEUTICS FOR TREATMENT OF ORGANOPHOSPHATE POISONING MISSISSIPI STATE UNIVERSITY (US) 2011-11-17 WO disclosed
EP-1917269-B1 INHIBITORS OF SERINE PROTEASES VERTEX PHARMA (US) 2011-10-26 EP disclosed
EP-2366704-A1 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-09-21 EP disclosed
EP-2364984-A1 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-09-14 EP disclosed
EP-1801102-B1 PROCESS FOR PRODUCTION OF 2-HYDROXY-4-SUBSTITUTED PYRIDINES YUKI GOSEI YAKUHIN KOGYO KK (JP) 2011-09-07 EP disclosed
US-20110200939-A1 POLYAMIC ACID, POLYIMIDE, PHOTOSENSITIVE RESIN COMPOSITION COMPRISING THE SAME AND DRY FILM MANUFACTURED BY THE SAME LG CHEM, LTD. (KR) 2011-08-18 US disclosed
US-20110195125-A1 Nanoparticles For Drug Delivery To The Central Nervous System SOUTHWEST RESEARCH INSTITUTE (US) 2011-08-11 US disclosed
EP-2323984-A1 TWO PHASE BIOACTIVE FORMULATIONS SOUTHWEST RESEARCH INSTITUTE (US) 2011-05-25 EP disclosed
US-7943619-B2 Isoxazolo-pyridazine derivatives HOFFMANN-LA ROCHE INC. (US) 2011-05-17 US disclosed
US-20110034697-A1 PROCESS FOR PREPARING 2-HYDROXY-4-SUBSTITUTED PYRIDINES YUKI GOSEI KOGYO CO., INC. (JP) 2011-02-10 US disclosed
US-20110027864-A1 PROCESS FOR PREPARING 2-HYDROXY-4-SUBSTITUTED PYRIDINES YUKI GOSEI KOGYO CO., INC. (JP) 2011-02-03 US disclosed
EP-2278967-A1 BIS-QUATERNARY PYRIDINIUM-ALDOYIME SALTS AND TREATMENT OF EXPOSURE TO CHOLINESTERASE INHIBITORS SOUTHWEST RESEARCH INSTITUTE (US) 2011-02-02 EP disclosed
US-20110015231-A1 ISOXAZOLE AND ISOTHIAZOLE COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATION AL-ABED YOUSEF 2011-01-20 US disclosed
US-20110009382-A1 Substituted Benzimidazoles, Benzothiazoles and Benzoxazoles GRUENENTHAL GMBH (DE) 2011-01-13 US disclosed
WO-2010142402-A1 SUBSTITUTED BENZIMIDAZOLES, BENZOTHIAZOLES AND BENZOXAZOLES Grünenthal GmbH (DE) 2010-12-16 WO disclosed
EP-2260043-A1 SUBSTITUTED SULFONAMIDE DERIVATIVES Grünenthal Gmbh (DE) 2010-12-15 EP disclosed
US-7843562-B2 Detection of biomolecules using porous biosensors and Raman spectroscopy INTEL CORPORATION (US) 2010-11-30 US disclosed
CN-101889010-A Isoxazolo-pyridine derivatives HOFFMANN LA ROCHE 2010-11-17 CN disclosed
CN-101868458-A Isoxazolo-pyridazine derivatives HOFFMANN LA ROCHE 2010-10-20 CN disclosed
US-7807696-B2 Isoxazole and isothiazole compounds useful in the treatment of inflammation THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH (US) 2010-10-05 US disclosed
EP-2231651-A1 ISOXAZOLO-PYRIDAZINE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2010-09-29 EP disclosed
US-7803585-B2 Process for preparing 2-Hydroxy-4-Substituted Pyridines YUKI GOSEI KOGYO CO., LTD. (JP) 2010-09-28 US disclosed
US-20100234340-A1 Substituted Spiroamide Compounds GRUENENTHAL GMBH (DE) 2010-09-16 US disclosed
EP-2227467-A1 ISOXAZOLO-PYRIDINE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2010-09-15 EP disclosed
US-7790759-B2 Glycyrrhetinic acid-30-amide derivatives and their use TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH (CN) 2010-09-07 US disclosed
US-20100222324-A1 Substituted Indole Compounds GRUENENTHAL GMBH (DE) 2010-09-02 US disclosed
WO-2010089084-A1 SUBSTITUTED INDOLE COMPOUNDS AS BRADYKININ RECEPTOR 1 MODULATORS Grünenthal GmbH (DE) 2010-08-12 WO disclosed
EP-1935892-B1 GLYCYRRHETINIC ACID-30-AMIDE DERIVATIVES AND THE USES THEREOF TIANJIN INST PHARM RESEARCH (CN) 2010-08-11 EP disclosed
WO-2010019398-A1 TWO PHASE BIOACTIVE FORMULATIONS SOUTHWEST RESEARCH INSTITUTE (US) 2010-02-18 WO disclosed
US-20100040692-A1 TWO PHASE BIOACTIVE FORMULATIONS SOUTHWEST RESEARCH INSTITUTE (US) 2010-02-18 US disclosed
US-20090281144-A1 Bis-quaternary pyridinium-aldoxime salts and treatment of exposure to cholinesterase inhibitors SOUTHWEST RESEARCH INSTITUTE (US) 2009-11-12 US disclosed
US-20090275558-A1 SUBSTITUTED SULFONAMIDE COMPOUNDS GRUENENTHAL GMBH (DE) 2009-11-05 US disclosed
WO-2009124746-A1 SUBSTITUTED SULFONAMIDE DERIVATIVES Grünenthal GmbH (DE) 2009-10-15 WO disclosed
WO-2009114298-A1 BIS-QUATERNARY PYRIDINIUM-ALDOXIME SALTS AND TREATMENT OF EXPOSURE TO CHOLINESTERASE INHIBITORS SOUTHWEST RESEARCH INSTITUTE (US) 2009-09-17 WO disclosed
EP-1503998-B1 HETEROARYL SUBSTITUTED SPIROCYCLIC SUFAMIDES FOR INHIBITION OF GAMMA SECRETASE MERCK SHARP & DOHME (GB) 2009-07-01 EP disclosed
WO-2009071477-A1 ISOXAZOLO-PYRIDAZINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2009-06-11 WO disclosed
WO-2009071476-A1 ISOXAZOLO-PYRIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2009-06-11 WO disclosed
US-20090143385-A1 ISOXAZOLO-PYRIDAZINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2009-06-04 US disclosed
US-20090143371-A1 ISOXAZOLE-PYRIDINE DERIVATIVES ROCHE PALO ALTO LLC 2009-06-04 US disclosed
US-7476874-B2 Self indicating radiation alert dosimeter JP LABORATORIES, INC. (US) 2009-01-13 US disclosed
EP-1352050-B1 MICROBIOLOGICAL METHOD FOR PRODUCING AMIDES LONZA AG (CH) 2008-12-17 EP disclosed
CN-101316852-A Inhibitors of serine proteases VERTEX PHARMA (US) 2008-12-03 CN disclosed
US-20080286843-A1 Process for Preparing 2-Hydroxy-Substituted Pyridines YUKI GOSEI KOGYO CO., INC. (JP) 2008-11-20 US disclosed
US-20080214636-A1 Glycyrrhetinic Acid-30-Amide Derivatives and Their Use TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH (CN) 2008-09-04 US disclosed
EP-1935892-A1 GLYCYRRHETINIC ACID-30-AMIDE DERIVATIVES AND THE USES THEREOF TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH (CN) 2008-06-25 EP disclosed
US-20080108131-A1 Detection of biomolecules using porous biosensors and Raman spectroscopy INTEL CORPORATION (US) 2008-05-08 US disclosed
EP-1711823-B1 DETECTION OF BIOMOLECULES USING POROUS BIOSENSORS AND RAMAN SPECTROSCOPY INTEL CORP (US) 2008-04-30 EP disclosed
US-20080070895-A1 Heteroaryl substituted spirocyclic sulfamides for inhibition of gamma secretase COLLINS IAN J 2008-03-20 US disclosed
US-7282513-B2 Heteroaryl substituted spirocyclic sulfamides for inhibition of gamma secretase MERCK SHARP & DOHME LIMITED (GB) 2007-10-16 US disclosed
CN-101052642-A Novel bis-azaindole derivatives, their preparation and their pharmaceutical use as kinase inhibitors AVENTIS PHARMA SA (FR) 2007-10-10 CN disclosed
CN-101048380-A Process for production of 2-hydroxy-4-substituted pyridines YUKI GOSEI YAKUHIN KOGYO KK (JP) 2007-10-03 CN disclosed
US-7271896-B2 Detection of biomolecules using porous biosensors and raman spectroscopy INTEL CORPORATION (US) 2007-09-18 US disclosed
EP-1801102-A1 PROCESS FOR PRODUCTION OF 2-HYDROXY-4-SUBSTITUTED PYRIDINES YUKI GOSEI KOGYO CO., LTD. (JP) 2007-06-27 EP disclosed
US-7227158-B1 Stick-on self-indicating instant radiation dosimeter JP LABS, INC. (US) 2007-06-05 US disclosed
CN-1950083-A Novel pyrrolo (2,3-b)pyridine derivatives, the preparation and the pharmaceutical use thereof in the form of kinase inhibitors AVENTIS PHARMA SA (FR) 2007-04-18 CN disclosed
CN-1922486-A Detection of biomolecules using porous biosensors and Raman spectroscopy INTEL CORP (US) 2007-02-28 CN disclosed
US-20070021465-A1 Anti-inflammatory compounds FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH, THE 2007-01-25 US disclosed
EP-1732546-A2 NOVEL PYRROLO (2,3-B)PYRIDINE DERIVATIVES, THE PREPARATION AND THE PHARMACEUTICAL USE THEREOF IN THE FORM OF KINASE INHIBITORS Aventis Pharma S.A. (FR) 2006-12-20 EP disclosed
US-20060173054-A1 Heteroaryl substituted spirocyclic sulfamides for inhibition of gamma secretase MERCK SHARP & DOHME (UK) LIMITED (GB) 2006-08-03 US disclosed
US-20060166906-A1 6-O-substituted erythromycin derivatives having improved gastrointestinal tolerance ABBOTT LABORATORIES 2006-07-27 US disclosed
US-20060145091-A1 Self indicating radiation alert dosimeter JP LABORATORIES INC. 2006-07-06 US disclosed
US-20060128759-A1 Substituted isoxazole derivatives and their use in pharmaceutics MERCKLE GMBH (DE) 2006-06-15 US disclosed
US-7053219-B2 Isoxazolopyridone derivatives and their use BANYU PHARMACEUTICAL CO. LTD. (JP) 2006-05-30 US disclosed
US-7041689-B2 Heteroaryl substituted spriocyclic sulfamides for inhibition of gamma secretase MERCK SHARP & DOHME LTD. (GB) 2006-05-09 US disclosed
EP-1599744-A2 SELF-INDICATING RADIATION ALERT DOSIMETER JP LABORATORIES, INC. (US) 2005-11-30 EP disclosed
WO-2005095399-A2 NOVEL PYRROLO (2,3-B)PYRIDINE DERIVATIVES, THE PREPARATION AND THE PHARMACEUTICAL USE THEREOF IN THE FORM OF KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2005-10-13 WO disclosed
US-20050196876-A1 Detection of biomolecules using porous biosensors and Raman spectroscopy INTEL CORPORATION (US) 2005-09-08 US disclosed
US-20050182109-A1 Heteroaryl substituted spriocyclic sulfamides for inhibition of gamma secretase MERCK SHARP & DOHME (UK) LIMITED (GB) 2005-08-18 US disclosed
US-20050147977-A1 Methods and compositions for nucleic acid detection and sequence analysis INTEL CORPORATION 2005-07-07 US disclosed
EP-1530468-A1 SUBSTITUTED ISOXAZOLE DERIVATIVES AND THEIR USE IN PHARMACEUTICS MERCKLE GMBH (DE) 2005-05-18 EP disclosed
WO-2005034952-A2 ISOXAZOLE AND ISOTHIAZOLE COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATION THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH (US) 2005-04-21 WO disclosed
EP-1503998-A1 HETEROARYL SUBSTITUTED SPIROCYCLIC SUFAMIDES FOR INHIBITION OF GAMMA SECRETASE MERCK SHARP &amp; DOHME LTD. (GB) 2005-02-09 EP disclosed
EP-1487445-A1 OBIDOXIME DIMESYLATE Drug Discovery Laboratory AS (NO) 2004-12-22 EP disclosed
WO-2004077097-A2 SELF-INDICATING RADIATION ALERT DOSIMETER JP LABORATORIES INC. (US) 2004-09-10 WO disclosed
US-20040176407-A1 Novel isoxazolopyridone derivatives and their use BANYU PHARMACEUTICAL CO., LTD. (JP) 2004-09-09 US disclosed
EP-1408042-A1 NOVEL ISOXAZOLOPYRIDONE DERIVATIVES AND USE THEREOF BANYU PHARMACEUTICAL CO., LTD. (JP) 2004-04-14 EP disclosed
WO-2004017968-A1 SUBSTITUTED ISOXAZOLE DERIVATIVES AND THEIR USE IN PHARMACEUTICS MERCKLE GMBH (DE) 2004-03-04 WO disclosed
WO-2003093252-A1 HETEROARYL SUBSTITUTED SPIROCYCLIC SULFAMIDES FOR INHIBITION OF GAMMA SECRETASE MERCK SHARP & DOHME LIMITED (GB) 2003-11-13 WO disclosed
EP-1352050-A1 MICROBIOLOGICAL METHOD FOR PRODUCING AMIDES LONZA AG (CH) 2003-10-15 EP disclosed
WO-2003082281-A1 OBIDOXIME DIMESYLATE DRUG DISCOVERY LABORATORY AS (NO) 2003-10-09 WO disclosed
EP-1328534-A2 6-O-SUBSTITUTED ERYTHROMYCIN DERIVATIVES HAVING IMPROVED GASTROINTESTINAL TOLERANCE Abbott Laboratories (US) 2003-07-23 EP disclosed
WO-2002055670-A1 MICROBIOLOGICAL METHOD FOR PRODUCING AMIDES LONZA AG (CH) 2002-07-18 WO disclosed
WO-2002032919-A2 6-O-SUBSTITUTED ERYTHROMYCIN DERIVATIVES HAVING IMPROVED GASTROINTESTINAL TOLERANCE ABBOTT LABORATORIES (US) 2002-04-25 WO disclosed
CN-1056840-C Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 2000-09-27 CN disclosed
CN-1056836-C 3,5-disubstituted and 3,4,5-trisubstituted 2-isoxazolines and isoxazoles, process for preparing same and their use as medicaments HOECHST AG (DE) 2000-09-27 CN disclosed
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
US-5929093-A PYRIDINIUM ALDOXIME SALTS; ANTIDOTES FOR ORGANOPHOSPHATE POISONING IN MAMMALS MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 1999-07-27 US disclosed
EP-0749429-B1 3,5-DISUBSTITUTED AND 3,5,6-TRISUBSTITUTED 2-ISOXAZOLINES AND ISOXAZOLES, PROCESS FOR PREPARING THE SAME AND THEIR USE AS MEDICAMENTS HOECHST AG (DE) 1999-06-30 EP disclosed
EP-0906773-A1 Decontaminating composition Etat-Francais représenté par le Délégué Général pour L'Armement (FR) 1999-04-07 EP disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
US-5814627-A ANTIINFLAMMATORY AGENTS, ASTHMA; RHEUMATIC AND AUTOIMMUNE DISEASES; INHIBITORS OF LEUKOTRIENES, CYTOKINES, E.G. INTERLEUKINS, OXYGEN RADICALS AND PROTEASES HOECHST AKTIENEGESELLSCHAFT (DE) 1998-09-29 US disclosed
US-5789138-A Optical recording medium and method of producing the same RICOH COMPANY, LTD. (JP) 1998-08-04 US disclosed
US-5780490-A A O-(2,4-OXA(OR THIA)ZOLIDINYL)PHENYLOXY(OR THIO OR AMINO) ALKYLOXIME; ALDOSE REDUCTASE INHIBITORS; ANTIDIABETIC AND -HYPOGLYCEMIC AGENTS; LIVER, SKIN AND UROGENITAL DISORDERS SANKYO COMPANY, LIMITED (JP) 1998-07-14 US disclosed
US-5756650-A COMPOSITION COMPRISING POLYAMIC ACID, CURE ACCELERATOR SELECTED FROM GROUP CONSISTING OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, AMINO ACID COMPOUND, AROMATIC COMPOUND HAVING TWO OR MORE HYDROXYL GROUPS KABUSHIKI KAISHA TOSHIBA (JP) 1998-05-26 US disclosed
US-5703096-A ANTIDIABETIC AGENTS; ALDOSE REDUCTASE INHIBITOR SANKYO COMPANY, LIMITED (JP) 1997-12-30 US disclosed
US-5663164-A CEPHALOSPORIN ANTIBIOTICS AS BACTERICIDES ROUSSEL UCLAF (FR) 1997-09-02 US disclosed
CN-1143639-A Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1997-02-26 CN disclosed
CN-1143956-A 3,5-disubstituted and 3,4,5-trisubstituted 2-isoxazolines and isoxazoles, process for preparing same and their use as medicaments HOECHST AG (DE) 1997-02-26 CN disclosed
EP-0749429-A1 3,5-DISUBSTITUTED AND 3,5,6-TRISUBSTITUTED 2-ISOXAZOLINES AND ISOXAZOLES, PROCESS FOR PREPARING THE SAME AND THEIR USE AS MEDICAMENTS HOECHST AKTIENGESELLSCHAFT (DE) 1996-12-27 EP disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed
WO-1995024397-A1 3,5-DISUBSTITUTED AND 3,5,6-TRISUBSTITUTED 2-ISOXAZOLINES AND ISOXAZOLES, PROCESS FOR PREPARING THE SAME AND THEIR USE AS MEDICAMENTS HOECHST AKTIENGESELLSCHAFT (DE) 1995-09-14 WO disclosed
US-5233044-A Pyrazolinone derivatives as self-indicating chromogens; monitoring coupling in peptide synthesis MILLIPORE CORPORATION (US) 1993-08-03 US disclosed
EP-0271798-B1 O-SUBSTITUTED TETRAHYDROPYRIDINE OXIME CHOLINERGIC AGENTS WARNER-LAMBERT COMPANY (US) 1993-04-07 EP disclosed
WO-1992017450-A1 BIS-METHYLENE ETHER PYRIDINIUM COMPOUND PREPARATION THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) 1992-10-15 WO disclosed
US-5130438-A Reaction of bis(methylsulfonoxymethyl)ether with pyridino-2-aldoxime and then isonicotinamide followed by ino exchanging chloride THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) 1992-07-14 US disclosed
US-4948912-A HALOACETOXYALKYL ETHER SOUTHWEST RESEARCH INSTITUTE (US) 1990-08-14 US disclosed
US-4786648-A ANALGESIC WARNER-LAMBERT COMPANY (US) 1988-11-22 US disclosed
US-4766136-A Phenylsulphonyl-pyridine aldoximes as fungicides BAYER AKTIENGESELLSCHAFT (DE) 1988-08-23 US disclosed
EP-0271798-A2 O-Substituted tetrahydropyridine oxime cholinergic agents WARNER-LAMBERT COMPANY (US) 1988-06-22 EP disclosed
US-4742070-A Arylsulphonyl-pyridinealdoxime derivatives, useful as fungicides BAYER AKTIENGESELLSCHAFT (DE) 1988-05-03 US disclosed
EP-0236919-A2 Phenylsulphonyl-pyridine aldoximes BAYER AG (DE) 1987-09-16 EP disclosed
EP-0236897-A1 Arylsulfonyl-pyridinealdoxime derivatives BAYER AG (DE) 1987-09-16 EP disclosed
US-4675044-A DEFOLIANTS UNIROYAL CHEMICAL COMPANY, INC. (US) 1987-06-23 US disclosed
US-4569690-A HERBICIDES, FUNGICIDES, PLANT DESSICANTS, DEFOLIANTS UNIROYAL, INC. (US) 1986-02-11 US disclosed
EP-0136640-A2 Trichloroacryloyloxime derivatives, process for their preparation and fungicides for agriculture NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1985-04-10 EP disclosed
US-4450270-A Dioximino cephalosporin antibiotics ELI LILLY AND COMPANY (US) 1984-05-22 US disclosed
EP-0104940-A1 3-Aryl-5,6-dihydro-1,4,2-oxathiazines and their oxides UNIROYAL, INC. (US) 1984-04-04 EP disclosed
US-4402955-A ZWITTERIONS; GRAMNEGATIVE BACTERIA ELI LILLY AND COMPANY (US) 1983-09-06 US disclosed
US-4384930-A Electroplating baths, additives therefor and methods for the electrodeposition of metals MCGEAN-ROHCO, INC. (US) 1983-05-24 US disclosed
US-4379787-A ANTIBIOTICS ELI LILLY AND COMPANY (US) 1983-04-12 US disclosed
US-4379787-A ANTIBIOTICS ELI LILLY AND COMPANY (US) 1983-04-12 US disclosed
US-4293391-A Cadmium plating baths and methods for electrodepositing bright cadmium deposits ROHCO, INC. (US) 1981-10-06 US disclosed
US-4270988-A PYRIDINE COMPOUNDS AS BRIGHTENERS ROHCO, INC. (US) 1981-06-02 US disclosed
US-4270989-A AN AQUEOUS SOLUTION OF A IONIZABLE CADMIUM COMPOUND, A FREE ACID, AND AN ALKYLENE OXIDE ADDUCT OR A POLYOXYALKYLENE GLYCOL HAVING A PHOSPHATE, CARBOXYLATE, OR ARYL SULFATE GROUP ROHCO, INC. (US) 1981-06-02 US disclosed
US-4038161-A ELECTRODEPOSITION, BATHS R. O. HULL & COMPANY, INC. (US) 1977-07-26 US disclosed
US-3948861-A Polyamide-imides from bis-imide and dialdoxime RHONE-POULENC S.A. (FR) 1976-04-06 US disclosed
US-3948861-A Polyamide-imides from bis-imide and dialdoxime RHONE-POULENC S.A. (FR) 1976-04-06 US disclosed